topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and COVID-19.

 

AAU submitted a response to the National Institutes of Health’s request for public comments to enhance public access to the results of NIH-supported research.
As lawmakers consider measures related to securing federally funded research data and intellectual property, it is important to understand the current state of play for research security in the country to avoid new requirements that are duplicative, unnecessary, or counterproductive
Nearly 400 members of the Ad Hoc Group for Medical Research, including AAU and many AAU member institutions, joined a statement recommending that Congress provide at least $50.924 billion for the National Institutes of Health in FY24.
An overview of the President's full proposed budget for FY24, including summaries and analyses for individual agencies.
UMR Urges House and Senate Leadership to Increase NIH Funding by $2.5 billion in FY 2023 Omnibus Appropriations bill.
The Ad Hoc Group for Medical Research, which includes AAU, sent a letter urging Congress to finalize FY23 funding for NIH, including at least $47.5 billion for the NIH’s base budget and strong supplemental investments in ARPA-H.
AAU and others asked the leaders of the House and Senate appropriations committees to include a robust investment of more than $49 billion in the FY23 spending package for the National Institutes of Health.
Representatives André Carson (D-In), David McKinley (R-WV), Suzan DelBene (D-WA), and Brian Fitzpatrick (R-PA) are circulating the below "Dear Colleague" letter encouraging House appropriators to provide for the NIH base budget “at least $49 billion and that any funding for the Advanced Research Projects Agency for Health should supplement, not supplant, this necessary growth in the NIH base budget” in FY23.
An overview of the President's full proposed budget for FY23, including summaries and analyses for individual agencies.